Loading, please wait...
CE Hours
3.50
CE Units
0.350
Activity Type
- Knowledge
Accreditation(s)
Participants have 60 days from the start of their program to claim CE credit and verify it has been upload to CPE Monitor. If your program requires the completion of a post test/eval/survey those items MUST be done before that 60 day window closes to receive credit for that program. Statements of credit can be viewed and printed from CPE Monitor. Statements of credit will no longer be printed and mailed to the participant. **No partial individual session credit will be given**
PAYMENT NOTE: During the registration process, if a fee is required, please enter the zip code associated with your credit card's BILLING ADDRESS. For security purposes payments are processed through a separate system, so when prompted, please click “ok” to be taken to that site and complete your registration. Upon successful registration of this program you will receive an email confirmation/receipt and will be returned to this program page. When you are retuned to this page you will see a note at the top of the page reading “You are registered for this program.”
If you are not automatically returned to this page or see only a blank white screen your transaction was not successful, and you will need to try again.
If paying by check please mail to the address below: 301 Pharmacy Lane, CB# 7574 Beard Hall
Chapel Hill, NC 27599
|
|
|
The University of North Carolina Eshelman School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. To receive CE credit, participants must complete the CE attendance form and the online evaluation of the program (instructions to be emailed). Statements of credit can be viewed and printed in CPE Monitor approximately 2 to 3 weeks after the program and you have completed any needed requirements. **No partial credit will be available**
|
Co-Sponsor(s)
UNC Health System
Support/Credits
Cancelations: Cancelations must be received in writing/email to the Office of Continuing Education at least 48 hours prior to start date to receive a full refund. No refunds will be given within 48 hours of the start date.
IMPORTANT: UNC HEALTH SYSTEM EMPLOYEES AND UNC ESHELMAN SCHOOL OF PHARMACY STUDENTS ONLY
UNC Health System Employees and ESOP Students are able to attend this Resident Series at no charge to them. If you are a Health System Employee or Student please follow the steps below. This only applies to this series. Other UNC ESOP CE programs are available to register at the fee listed on that page.
- UNC Health System Employees and UNC ESOP Students should register using your UNC email address. UNC Employees - please select your employment location during the registration process. UNC Students - please respond "Yes" to the "Are you a UNC Student" question.
- Select the “Check” payment method on the registration page. Your employment will be verified prior to credit being uploaded
Program Materials: A link to the program recording and presentation slides will be found under the session by expanding the module after completing registration. Once the content has been completed return to this page to complete the post assessment and evaluation. After those have been submitted your credit will automattically be uploaded to CPE Monitor.
In September 2015, The NC General Assembly passed a law that directed that the North Carolina Medicaid program switch from a primarily fee-for-service model to a capitated managed care structure. This transition aims to improve care delivery, improve the health of North Carolinians, and pay for value rather than volume. This Medicaid transition has the potential for a significant impact on our practices at UNC Health and all health-systems across the state.
Objectives
- Outline the difference between managed care and fee-for-service
- Describe the goals of the NC Managed Medicaid transition
Speaker(s)/Author(s)
|
Greg Norsten, PharmD
|
Activity Number
0046-9999-21-220-H04-P
Release Date:
Sep 2, 2021
Credit Expiration Date:
Sep 2, 2022
CE Hours
0.50
Fee
$5.00
This session will provide insight to the intended role that biosimilar products serve in reducing healthcare costs and the challenges associated with adopting biosimilars for use.
Objectives
- Define a biosimilar
- Describe the approval process for a biosimilar
- Outline advantages and disadvantages to implementing biosimilars
- Discuss strategies for implementing biosimilars
Speaker(s)/Author(s)
|
Connor McKay, PharmD
|
Activity Number
0046-9999-21-214-H04-P
Release Date:
Sep 2, 2021
Credit Expiration Date:
Sep 2, 2022
CE Hours
0.50
Fee
$5.00
Objectives
- Describe the anatomical features and physiologic impact of patent ductus arteriosus (PDA) in neonates
- Review the potential complications of patent ductus arteriosus and indications for treatment
- Compare and contrast therapeutic interventions for closing PDAs
Speaker(s)/Author(s)
|
Erin Brown, PharmD
|
Activity Number
0046-9999-21-230-H01-P
Release Date:
Sep 9, 2021
Credit Expiration Date:
Sep 9, 2022
CE Hours
1.00
Fee
$10.00
This will discuss the real world utility of new C.difficile (italics) treatments in accordance with recent guideline updates.
Objectives
- Discuss epidemiology, pathogenesis and risk factors associated with Clostridioides Difficile Infection (CDI)
- Describe recent updates to the pharmacologic treatment of C. Difficile Infection
- Analyze literature regarding the use of fidaxomicin and bezlotoxumab
- Assess the real world utility of fidaxomicin and bezlotoxumab in the management of CDI
Speaker(s)/Author(s)
|
Ethan Rausch, PharmD
|
Activity Number
0046-9999-21-232-H01-P
Release Date:
Sep 23, 2021
Credit Expiration Date:
Sep 23, 2022
CE Hours
1.00
Fee
$10.00
This CE is an introduction to a novel area in pharmacy called digital therapeutics. It will review its place in digital health, associated regulatory pathways, and prescription digital therapeutic agents on the market that have been adopted to digital health formularies.
Presentation Slides available for download at the bottom of this module. You MUST be signed into your registered account to access this content
Objectives
- Describe digital therapeutics and associated regulatory pathways.
- Review examples of digital therapeutic agents on the market and the adoption of digital health formularies
Speaker(s)/Author(s)
|
Jennifer Sato, PharmD
|
Activity Number
0046-9999-21-236-H04-P
Release Date:
Sep 30, 2021
Credit Expiration Date:
Sep 30, 2022
CE Hours
0.50
Fee
$5.00